You are viewing a free preview of this lesson.
Subscribe to unlock all 10 lessons in this course and every other course on LearningBro.
Spec mapping (AQA 7037): Paper 2, §3.2.4 Population and the Environment — the spatial diffusion of disease; the prevalence, distribution and management of a named disease; the role of international agencies and non-governmental organisations in the management of health and disease; the geography of healthcare provision and access. This lesson applies the health geography of the previous lesson to specific diseases and to the governance of health, linking strongly to §3.2.1 Global Systems and Global Governance (the WHO and global health are a flagship example of global governance, its achievements and its failures). It also links synoptically to §3.1.1 (climate and land-use change drive the emergence and diffusion of disease). Assessment objectives: AO1 — knowledge of disease diffusion, named diseases (malaria, HIV/AIDS, COVID-19, TB), the WHO and non-state actors; AO2 — application to real diseases, outbreaks and institutions; AO3 — evaluation of the effectiveness of global health governance and of the causes of health inequality, to reach a substantiated judgement.
This lesson examines how disease spreads (spatial diffusion), how named diseases are managed, how global institutions govern health, and the persistent inequalities that shape access to healthcare. You will study the WHO, the COVID-19 pandemic, and case studies of malaria, HIV/AIDS and TB.
A core AO1 idea is diffusion — how a disease spreads across space and through a population. Geographers (following Torsten Hägerstrand) distinguish several types:
| Type of diffusion | Mechanism | Example |
|---|---|---|
| Expansion diffusion | Spreads outward from a source while the source remains infected | A disease radiating out from an initial outbreak area |
| Contagious (contact) diffusion | Spreads through direct person-to-person contact, strongly affected by distance | Ebola spreading between neighbouring villages |
| Hierarchical diffusion | Jumps down an urban hierarchy — from large hubs to smaller settlements — often via transport links | COVID-19 reaching major global cities first, then spreading to smaller towns |
| Relocation diffusion | The disease moves with infected people, leaving the origin | Cholera carried by travellers; COVID-19 spread internationally by air passengers |
The barriers that slow or stop diffusion are central to management: physical distance and isolation, but above all interventions — quarantine, border closures, travel restrictions, vaccination (which raises the herd-immunity threshold), and behavioural change. The classic geographical insight, dating to John Snow's mapping of the 1854 Soho cholera outbreak — which traced cases to the Broad Street water pump and helped found epidemiology — is that mapping where a disease occurs reveals how it spreads and how to stop it. Modern disease surveillance applies exactly this principle at global scale.
The World Health Organization was established in 1948 as a specialised agency of the United Nations, headquartered in Geneva, Switzerland. Its mandate is to promote health, keep the world safe, and serve the vulnerable.
| Function | Description | Example |
|---|---|---|
| Setting norms and standards | Issues guidelines on disease control, air quality, nutrition | WHO Air Quality Guidelines (updated 2021) |
| Disease surveillance | Monitors global disease outbreaks and declares Public Health Emergencies of International Concern (PHEICs) | COVID-19 PHEIC declared 30 January 2020 |
| Coordinating international response | Mobilises resources, experts, and logistics during health emergencies | Ebola response in West Africa (2014–16) |
| Technical assistance | Supports countries in strengthening health systems | Training healthcare workers in LICs |
| Research and innovation | Funds and coordinates global health research | COVAX initiative for equitable vaccine distribution |
Strengths:
Weaknesses:
A useful evaluative frame is the distinction between the WHO's normative role (setting standards and guidelines — which it does well and authoritatively) and its operational role (mobilising a rapid, resourced response on the ground — where it is hampered by funding and the lack of any power to override sovereign states). Much of the criticism after COVID-19 conflated the two: the WHO's advice was generally sound, but it could not compel states to follow it or to share vaccines, because the organisation depends on the voluntary cooperation and contributions of the very governments it is meant to coordinate. This structural dependency — not incompetence — is the root of its limitations, and explains why reform proposals focus on guaranteed core funding and binding commitments.
Key Definition: A pandemic is an outbreak of disease that occurs across a wide geographic area (typically multiple countries or continents) and affects an exceptionally large proportion of the population. An epidemic is a comparable surge confined to a region or country; an endemic disease is one constantly present at a baseline level in a population (malaria is endemic across much of the tropics).
Understanding the escalation from outbreak to epidemic to pandemic is central to disease governance, because the response thresholds differ at each level. A localised outbreak may be containable by local public health; an epidemic demands a coordinated national response; a pandemic requires international coordination — surveillance, information-sharing, travel measures and the equitable distribution of countermeasures — which is precisely where the WHO's powers (and limits) come into play. COVID-19's progression from a December 2019 cluster in Wuhan to a global pandemic within three months, accelerated by air travel (hierarchical and relocation diffusion), shows how globalisation has compressed the timescale of escalation, leaving far less time for containment than in earlier eras and placing a premium on rapid, coordinated global governance.
COVID-19, caused by the SARS-CoV-2 virus, was the most significant global health emergency since the 1918 influenza pandemic.
Key Timeline:
Global Impact:
| Indicator | Data |
|---|---|
| Confirmed cases | Over 770 million (WHO, 2023) |
| Confirmed deaths | Over 7 million; excess mortality estimated at 14.9 million (WHO) |
| Vaccines administered | Over 13.5 billion doses |
| Economic cost | Estimated $12.5 trillion in global GDP losses (2020–2022) |
The pandemic starkly revealed and worsened existing health inequalities:
| Dimension of Inequality | Evidence |
|---|---|
| Within countries | In the UK, COVID-19 mortality was highest in the most deprived areas and among Black and South Asian communities (PHE, 2020) |
| Between countries | By late 2021, over 80% of people in HICs had received at least one vaccine dose; in LICs, it was below 10% |
| Vaccine inequality | COVAX (the global vaccine-sharing initiative) fell far short of its target — HICs hoarded supplies through bilateral deals |
| Economic impact | LICs and MICs lacked fiscal capacity for furlough schemes and social protection; informal workers were worst affected |
| Gender | Women disproportionately bore the burden of increased care work, domestic violence, and job losses in service sectors |
| Occupation | "Key workers" in lower-paid, customer-facing roles (transport, retail, care) faced far higher exposure and mortality than those able to work from home |
| Housing | Overcrowded and multigenerational housing accelerated transmission, compounding deprivation effects |
COVID-19 is also the clearest modern illustration of disease diffusion and its management. Its global spread combined relocation diffusion (carried by international air passengers from Wuhan to the world within weeks) and hierarchical diffusion (reaching major global hub cities — London, New York, Milan — first, then cascading down to smaller towns), before becoming contagious at the local scale. This pattern dictated the management toolkit governments deployed to erect barriers to diffusion:
The starkly different national outcomes — compare the early elimination strategies of New Zealand and Taiwan with the high mortality of the UK, USA and Brazil — show that governance and policy choices, not just the virus, shaped the death toll, reinforcing the lesson's theme that health outcomes are socially and politically produced.
Exam Tip: COVID-19 is an excellent case study for demonstrating how health outcomes are shaped by socio-economic factors, governance, and global inequality. Use specific data (mortality rates by deprivation decile, vaccination rates by income group) to support your arguments — and link the spatial diffusion (relocation/hierarchical) to the management strategies that target each type.
The "big three" infectious diseases — malaria, HIV/AIDS and tuberculosis — together still kill over two million people a year and illustrate the persistence of communicable disease in the world's poorest regions even as non-communicable disease rises globally. They share a common geography: each is concentrated in LICs and among the poorest populations, each is shaped by the interaction of environment, poverty and governance, and each is a target of coordinated global action (the Global Fund to Fight AIDS, Tuberculosis and Malaria, established 2002, channels billions in financing). Studying them together reveals both the achievements of global health governance — millions of deaths averted — and its fragility, as progress on all three stalled during the COVID-19 pandemic and is now threatened by drug resistance and funding constraints.
Malaria is the ideal named disease for examining management at multiple scales. At the local scale, distribution is controlled by the Anopheles mosquito's need for warmth (~18–32°C) and standing water, so management targets the vector — bed nets, indoor spraying, draining breeding sites. At the national scale, the contrast between countries that have eliminated malaria (much of North Africa, Sri Lanka certified malaria-free in 2016, China in 2021) and those where it persists shows that governance, funding and health-system strength are decisive: the physical environment sets the potential, but human action determines the outcome. At the global scale, coordinated funding through the Global Fund and the Gates Foundation, plus the rollout of the RTS,S and R21 vaccines, has driven the long-run decline. The recent stalling of progress — driven by insecticide and artemisinin resistance, funding plateaus and COVID-19 disruption, with climate change threatening to expand the disease's range — is a sobering reminder that even a managed disease can rebound, and that biomedical victories must be sustained against an evolving pathogen.
HIV/AIDS rewards detailed study as a named disease because its distribution, diffusion and management are all geographically instructive. Its distribution is highly uneven — sub-Saharan Africa carries ~two-thirds of the global total, with the heaviest burden in southern and eastern Africa, while prevalence is lower but concentrated in particular groups (men who have sex with men, sex workers, people who inject drugs) in HICs. Its diffusion historically followed transport corridors and migration routes — major truck routes, mining areas with migrant male labour, and urban centres acted as foci from which the virus spread, a clear example of contagious and relocation diffusion shaped by economic geography. Its management combines prevention (condoms, male circumcision, education, and pre-exposure prophylaxis / PrEP) with treatment (antiretroviral therapy, which both keeps patients alive and, by suppressing viral load, prevents transmission — "treatment as prevention", or U=U, undetectable = untransmittable). The goal is now the UNAIDS 95-95-95 target (95% of those with HIV diagnosed, 95% of those on treatment, 95% of those virally suppressed). The disease thus shows how a global health threat is shaped by local economic geography and tackled through a combination of biomedical innovation, behaviour change and sustained international funding — and how that progress remains fragile where stigma, inequality or funding cuts persist.
Subscribe to continue reading
Get full access to this lesson and all 10 lessons in this course.